December 8, 2021

Arunachal Front

Complete News World

Pfizer Laboratory seeks approval for its pill against Covit-19 in the United States

As part of the five-day treatment, the company says it has developed an effective antiviral drug against the disease. But medical information has not yet been reviewed by health officials and independent experts.

Article written by


Study time: 2 min

On Tuesday, November 16, Pfizer announced that it was seeking emergency approval in the United States for the anti-Govt pill. This treatment is eagerly awaited because it can be easily taken at home in the first days after the onset of symptoms in case of infection. The pharmaceutical company has filed this claim with the FDA. Specifies the message (In English).

This antiviral treatment, marketed under the name Paxlovid, has been shown to be 89% effective against hospitalizations and mortality in clinical trials taken within three days of the onset of symptoms. The company conducted the tests on people at high risk of developing Covit-19’s serious illness. They took the medication every 12 hours for five days. However, we must be careful because the studies have not yet been made public. The data should now be analyzed by US authority.

“Our clinical study of Paxlovit underscores the enormous efficacy and potential of antiviral therapies that play an important role in the fight against Govt-19, saving lives and helping to keep people out of the hospital if allowed.”, Albert Borla, Pfizer’s boss, quoted in a statement. Antivirals work by reducing the replication ability of a virus, thus slowing down the course of the disease. These therapies are the main complement of vaccines to protect against Govt-19.

See also  Vladimir Putin announces legislation to exclude opponents from elections in Russia

The Washington Post The US government has said It is scheduled to be announced this week (In English) 10 million treatments purchased. Pfizer plans to invest up to $ 1 billion in the production and distribution of Foxlovit. A voluntary licensing agreement with the Drugs Patent Committee (MPP) was also announced. 95 General manufacturers should be allowed to produce drugs for supply to middle- and low-income countries.

>> Govit 19 anti-pill from Merck Lab: “We should not expect a miracle drug”, Professor Matthew Molimart estimates

The US laboratory Merck has developed an antiviral treatment that was approved in the UK in early November. Washington has already purchased 3.1 million treatments from Merck and the FDA panel will meet on November 30 to decide on the application for accreditation for Merck treatment in the United States.